Lei Yang1,2, Xiafei Li3, Yiting Wu4, Pengchong Du1,5, Lulu Sun1, Zhenyang Yu2, Shuang Song1, Jianshen Yin1, Xianfen Ma1, Changqin Jing1, Junqiang Zhao3, Hongli Chen1, Yuzhen Dong2, Qiqing Zhang1, Liang Zhao1,6,7. 1. College of Life Science and Technology, Xinxiang Medical University, Xinxiang, People's Republic of China. 2. Department of Orthopedics, First Affiliated Hospital, Xinxiang Medical University, Xinxiang, People's Republic of China. 3. College of Medical Engineering, Xinxiang Medical University, Xinxiang, People's Republic of China. 4. Xiacun Community Health Service Center, Shenzhen Hospital, University of Chinese Academy of Sciences, Shenzhen, People's Republic of China. 5. Department of Cardio-Thoracic Surgery, Third Affiliated Hospital, Xinxiang Medical University, Xinxiang, People's Republic of China. 6. Key Laboratory of Cardiac Structure Research, Zhengzhou Seventh People's Hospital, Zhengzhou, People's Republic of China. 7. The Central Lab, The Third People's Hospital of Datong, Datong, People's Republic of China.
Abstract
PURPOSE: The development of tissue-engineered blood vessels provides a new source of donors for coronary artery bypass grafting and peripheral blood vessel transplantation. Fibrin fiber has good biocompatibility and is an ideal tissue engineering vascular scaffold, but its mechanical property needs improvement. METHODS: We mixed polyurethane (PU) and fibrin to prepare the PU/fibrin vascular scaffolds by using electrospinning technology in order to enhance the mechanical properties of fibrin scaffold. We investigated the morphological, mechanical strength, hydrophilicity, degradation, blood and cell compatibility of PU/fibrin (0:100), PU/fibrin (5:95), PU/fibrin (15:85) and PU/fibrin (25:75) vascular scaffolds. Based on the results in vitro, PU/fibrin (15:85) was selected for transplantation in vivo to repair vascular defects, and the extracellular matrix formation, vascular remodeling, and immune response were evaluated. RESULTS: The results indicated that the fiber diameter of the PU/fibrin (15:85) scaffold was about 712nm. With the increase of PU content, the mechanical strength of the composite scaffolds increased, however, the degradation rate decreased gradually. The PU/fibrin scaffold showed good hydrophilicity and hemocompatibility. PU/fibrin (15:85) vascular scaffold could promote the adhesion and proliferation of mesenchymal stromal cells (MSCs). Quantitative RT-PCR experimental results showed that the expression of collagen, survivin and vimentin genes in PU/fibrin (15:85) was higher than that in PU/fibrin (25:75). The results in vivo indicated the mechanical properties and compliance of PU/fibrin grafts could meet clinical requirements and the proportion of thrombosis or occlusion was significantly lower. The graft showed strong vasomotor response, and the smooth muscle cells, endothelial cells, and ECM deposition of the neoartery were comparable to that of native artery after 3 months. At 3 months, the amount of macrophages in PU/fibrin grafts was significantly lower, and the secretion of pro-inflammatory and anti-inflammatory cytokines decreased. CONCLUSION: PU/fibrin (15:85) vascular scaffolds had great potential to be used as small-diameter tissue engineering blood vessels.
PURPOSE: The development of tissue-engineered blood vessels provides a new source of donors for coronary artery bypass grafting and peripheral blood vessel transplantation. Fibrin fiber has good biocompatibility and is an ideal tissue engineering vascular scaffold, but its mechanical property needs improvement. METHODS: We mixed polyurethane (PU) and fibrin to prepare the PU/fibrin vascular scaffolds by using electrospinning technology in order to enhance the mechanical properties of fibrin scaffold. We investigated the morphological, mechanical strength, hydrophilicity, degradation, blood and cell compatibility of PU/fibrin (0:100), PU/fibrin (5:95), PU/fibrin (15:85) and PU/fibrin (25:75) vascular scaffolds. Based on the results in vitro, PU/fibrin (15:85) was selected for transplantation in vivo to repair vascular defects, and the extracellular matrix formation, vascular remodeling, and immune response were evaluated. RESULTS: The results indicated that the fiber diameter of the PU/fibrin (15:85) scaffold was about 712nm. With the increase of PU content, the mechanical strength of the composite scaffolds increased, however, the degradation rate decreased gradually. The PU/fibrin scaffold showed good hydrophilicity and hemocompatibility. PU/fibrin (15:85) vascular scaffold could promote the adhesion and proliferation of mesenchymal stromal cells (MSCs). Quantitative RT-PCR experimental results showed that the expression of collagen, survivin and vimentin genes in PU/fibrin (15:85) was higher than that in PU/fibrin (25:75). The results in vivo indicated the mechanical properties and compliance of PU/fibrin grafts could meet clinical requirements and the proportion of thrombosis or occlusion was significantly lower. The graft showed strong vasomotor response, and the smooth muscle cells, endothelial cells, and ECM deposition of the neoartery were comparable to that of native artery after 3 months. At 3 months, the amount of macrophages in PU/fibrin grafts was significantly lower, and the secretion of pro-inflammatory and anti-inflammatory cytokines decreased. CONCLUSION: PU/fibrin (15:85) vascular scaffolds had great potential to be used as small-diameter tissue engineering blood vessels.
Authors: Faisal M Shaikh; Anthony Callanan; Eamon G Kavanagh; Paul E Burke; Pierce A Grace; Tim M McGloughlin Journal: Cells Tissues Organs Date: 2008-06-13 Impact factor: 2.481
Authors: Jason D Roh; Rajendra Sawh-Martinez; Matthew P Brennan; Steven M Jay; Lesley Devine; Deepak A Rao; Tai Yi; Tamar L Mirensky; Ani Nalbandian; Brooks Udelsman; Narutoshi Hibino; Toshiharu Shinoka; W Mark Saltzman; Edward Snyder; Themis R Kyriakides; Jordan S Pober; Christopher K Breuer Journal: Proc Natl Acad Sci U S A Date: 2010-03-05 Impact factor: 11.205
Authors: Nuno Alexandre; Jorge Ribeiro; Andrea Gärtner; Tiago Pereira; Irina Amorim; João Fragoso; Ascensão Lopes; João Fernandes; Elísio Costa; Alice Santos-Silva; Miguel Rodrigues; José Domingos Santos; Ana Colette Maurício; Ana Lúcia Luís Journal: J Biomed Mater Res A Date: 2014-02-14 Impact factor: 4.396
Authors: Juan Antonio Rojas-Murillo; Mario A Simental-Mendía; Nidia K Moncada-Saucedo; Paulina Delgado-Gonzalez; José Francisco Islas; Jorge A Roacho-Pérez; Elsa N Garza-Treviño Journal: Int J Mol Sci Date: 2022-08-30 Impact factor: 6.208
Authors: María A Rodríguez-Soto; Camilo A Polanía-Sandoval; Andrés M Aragón-Rivera; Daniel Buitrago; María Ayala-Velásquez; Alejandro Velandia-Sánchez; Gabriela Peralta Peluffo; Juan C Cruz; Carolina Muñoz Camargo; Jaime Camacho-Mackenzie; Juan Guillermo Barrera-Carvajal; Juan Carlos Briceño Journal: Polymers (Basel) Date: 2022-08-23 Impact factor: 4.967